Vaxcyte, Inc.
PCVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $281 | $307 | $347 | $388 |
| Short-Term Investments | $1,430 | $1,355 | $1,325 | $1,359 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $55 | $54 | $45 | $41 |
| Total Curr. Assets | $1,767 | $1,716 | $1,717 | $1,788 |
| Property Plant & Equip (Net) | $337 | $328 | $305 | $333 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $961 | $1,165 | $1,279 | $1,388 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $107 | $97 | $78 | $3 |
| Total NC Assets | $1,404 | $1,590 | $1,662 | $1,723 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,172 | $3,305 | $3,378 | $3,511 |
| Liabilities | – | – | – | – |
| Payables | $49 | $31 | $21 | $48 |
| Short-Term Debt | $6 | $6 | $6 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $145 | $117 | $70 | $86 |
| Total Curr. Liab. | $200 | $154 | $97 | $140 |
| LT Debt | $79 | $80 | $81 | $65 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $79 | $80 | $81 | $65 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $79 | $86 | $87 | $71 |
| Total Liabilities | $279 | $234 | $178 | $205 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,908 | -$1,696 | -$1,529 | -$1,388 |
| AOCI | $1 | -$2 | -$0 | -$4 |
| Other Equity | $4,800 | $4,769 | $4,729 | $4,698 |
| Total Equity | $2,893 | $3,071 | $3,200 | $3,306 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,172 | $3,305 | $3,378 | $3,511 |
| Net Debt | -$197 | -$221 | -$260 | -$317 |